The results showed no obvious pathological changes in blood biochemical indexes (Figure3; Figure S2, Supporting Information) and organs (Figure S4, Supporting Information) compared with control littermates, suggesting that CYP2E1 is a safe potential target for glioma. This evidence concerns the gene CYP2E1 and central nervous system cancer.